Haloperidol Decanoate Injection

Name: Haloperidol Decanoate Injection

What are some side effects that I need to call my doctor about right away?

WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect:

  • Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
  • Trouble controlling body movements, twitching, change in balance, trouble swallowing or speaking.
  • Very bad dizziness or passing out.
  • Shakiness, trouble moving around, or stiffness.
  • Not able to pass urine.
  • Feeling very tired or weak.
  • Any unexplained bruising or bleeding.
  • Change in eyesight.
  • Hallucinations (seeing or hearing things that are not there).
  • Seizures.
  • Mood changes.
  • Enlarged breasts.
  • Change in sex ability.
  • For women, no period.
  • Nipple discharge.
  • Some people who take this medicine may get a very bad muscle problem called tardive dyskinesia. This muscle problem may not go away even if haloperidol decanoate injection is stopped. Sometimes, signs may lessen or go away over time after this medicine is stopped. The risk of tardive dyskinesia may be greater in people with diabetes and in older adults, especially older women. The risk is also greater the longer you take haloperidol decanoate injection or with higher doses. Muscle problems may also occur after short-term use with low doses. Call your doctor right away if you have trouble controlling body movements or if you have muscle problems with your tongue, face, mouth, or jaw like tongue sticking out, puffing cheeks, mouth puckering, or chewing.
  • Call your doctor right away if you have a painful erection (hard penis) or an erection that lasts for longer than 4 hours. This may happen even when you are not having sex. If this is not treated right away, it may lead to lasting sex problems and you may not be able to have sex.
  • Some people have gotten pneumonia when taking this medicine. Sometimes, this has been deadly. Call your doctor right away if you have fever, chest pain, cough, shortness of breath, or wheezing.

If OVERDOSE is suspected

If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened.

How do I store and/or throw out Haloperidol Decanoate Injection?

  • If you need to store haloperidol decanoate injection at home, talk with your doctor, nurse, or pharmacist about how to store it.
  • Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.
  • Check with your pharmacist about how to throw out unused drugs.

Haloperidol Decanoate Injection - Clinical Pharmacology


Haloperidol Decanoate Injection, 50 mg/mL and Haloperidol Decanoate Injection, 100 mg/mLare the long-acting forms of haloperidol. The basic effects of haloperidol decanoate are no different from those of haloperidol with the exception of duration of action. Haloperidol blocks the effects of dopamine and increases its turnover rate; however, the precise mechanism of action is unknown.
Administration of haloperidol decanoate in sesame oil results in slow and sustained release of haloperidol. The plasma concentrations of haloperidol gradually rise, reaching a peak at about 6 days after the injection, and falling thereafter, with an apparent half-life of about 3 weeks. Steady state plasma concentrations are achieved after the third or fourth dose. The relationship between dose of haloperidol decanoate and plasma haloperidol concentration is roughly linear for doses below 450 mg. It should be noted, however, that the pharmacokinetics of haloperidol decanoate following intramuscular injections can be quite variable between subjects.

Overdosage


While overdosage is less likely to occur with a parenteral than with an oral medication, information pertaining to haloperidol is presented, modified only to reflect the extended duration of action of haloperidol decanoate.

Manifestations


In general, the symptoms of overdosage would be an exaggeration of known pharmacologic effects and adverse reactions, the most prominent of which would be: 1) severe extrapyramidal reactions, 2) hypotension, or 3) sedation. The patient would appear comatose with respiratory depression and hypotension which could be severe enough to produce a shock-like state. The extrapyramidal reactions would be manifested by muscular weakness or rigidity and a generalized or localized tremor, as demonstrated by the akinetic or agitans types, respectively. With accidental overdosage, hypertension rather than hypotension occurred in a two-year old child. The risk of ECG changes associated with torsade de pointes should be considered.
(For further information regarding torsade de pointes, please refer to ADVERSE REACTIONS.)

Treatment


Since there is no specific antidote, treatment is primarily supportive. A patent airway must be established by use of an oropharyngeal airway or endotracheal tube or, in prolonged cases of coma, by tracheostomy. Respiratory depression may be counteracted by artificial respiration and mechanical respirators. Hypotension and circulatory collapse may be counteracted by use of intravenous fluids, plasma, or concentrated albumin, and vasopressor agents such as metaraminol, phenylephrine and norepinephrine. Epinephrine should not be used. In case of severeextrapyramidal reactions, antiparkinson medication should be administered, and should be continued for several weeks, and then withdrawn gradually as extrapyramidal symptoms may emerge. ECG and vital signs should be monitored especially for signs of Q-T prolongation or dysrhythmias and monitoring should continue until the ECG is normal. Severe arrhythmias should be treated with appropriate anti-arrhythmic measures.

How is Haloperidol Decanoate Injection Supplied


Haloperidol Decanoate Injection, 50 mg haloperidol as 70.52 mg  per mL haloperidol decanoate is available as follows:

NDC
Haloperidol Decanoate Injection
  Package Factor
68083-137-10
50 mg/mL*,1 mL vial
 10 vials per carton
68083-137-02
250 mg/5 mL* (50 mg/mL), 5 mL multiple  dose vial
  1 vial per carton

Haloperidol Decanoate Injection, 100 mg haloperidol as 141.04 mg per mL haloperidol decanoate is available as follows:

NDC
Haloperidol Decanoate Injection
  Package Factor
68083-138-10
100 mg/mL*,1 mL vial
 10 vials per carton
68083-138-02
500 mg/5 mL* (100 mg/mL), 5 mL multiple  dose vial
  1 vial per carton

* As haloperidol
 

Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].


Do not refrigerate or freeze.
PROTECT FROM LIGHT.
Keep in carton until empty.

Manufactured by:
Gland Pharma Limited
D.P.Pally, Dundigal Post,


Hyderabad-500 043, INDIA.

March 2017

(web3)